Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722878 · ClinicalTrials.gov registry record
Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung Disease
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 48
- Enrollment target
NCT00722878 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 48 participants.
The verdict
NCT00722878 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
Primary ciliary dyskinesia (PCD), also known as Kartagener syndrome, is a genetic disorder of the cilia, which are microscopic hair-like cells. Cilia work to keep the respiratory system clean by moving mucus that contains debris to the large airways, where it can be coughed out. People with PCD have cilia that do not move properly and therefore are not effective in cleaning the respiratory system. This study will determine when PCD starts and how it changes over time, specifically in terms of how well the lungs work, what germs grow in lung secretions, and how the lungs look on computed tomography (CT) scans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2008-07 |
| Est. Completion | 2019-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00722878
The ClinicalTrials.gov registry entry for NCT00722878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00722878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00722878 about?
NCT00722878 is a clinical study titled "Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung Disease". Primary ciliary dyskinesia (PCD), also known as Kartagener syndrome, is a genetic disorder of the cilia, which are microscopic hair-like cells. Cilia work to keep the respiratory system clean by moving mucus that contains debris to the large airways, where it can be coughed out. People with PCD have...
What is the current status of trial NCT00722878?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2008-07. Estimated completion is 2019-08.
Who is sponsoring clinical trial NCT00722878?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.